A detailed history of Dimensional Fund Advisors LP transactions in Scynexis Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 14,997 shares of SCYX stock, worth $29,994. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,997
Previous 14,997 -0.0%
Holding current value
$29,994
Previous $33,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

BUY
$1.56 - $2.24 $7,781 - $11,173
4,988 Added 49.84%
14,997 $33,000
Q3 2023

Nov 09, 2023

BUY
$1.93 - $3.64 $19,317 - $36,432
10,009 New
10,009 $22,000
Q4 2022

Feb 09, 2023

SELL
$1.46 - $2.49 $7,197 - $12,275
-4,930 Reduced 28.99%
12,076 $18,000
Q3 2022

Nov 10, 2022

BUY
$1.83 - $2.93 $31,120 - $49,827
17,006 New
17,006 $41,000

Others Institutions Holding SCYX

About SCYNEXIS INC


  • Ticker SCYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 32,651,800
  • Market Cap $65.3M
  • Description
  • SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...
More about SCYX
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.